Cáncer de colon con metástasis a glándula suprarrenal
Bibliografía
Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990. Cancer J Clin 40:9-26. 1990.
The M.D. Anderson Surgical Oncology Handbook, Second Edition, 178.
Scheele J, Stangl R et al. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. British Journal of Surgery 77 (11): 1241-1246, 1990.
Steele G, Bleday R, Mayer RJ, et al: A prospective evaluation of hepatic resection of colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. Journal of Clinical Oncology. 9 (7): 1105-1112, 1991.
Harmon KE, Ryan JA Jr, et al: Benefits and safety of hepatic resection for colorectal metastases. American Journal of Surgery. 177 (5), 402-404, 1999.
Adson MA, van Heerden JA, Wagner JS, et al: Resection of hepatic metastases from colorectal cancer. Archives of Surgery. 119(6): 647-651, 1984.
Taylor M, Forster J, Langer B et al: A study of prognostic factors for hepatic resection for colorectal metastases. American Journal of Surgery 173(6): 467-471, 1997.
Seifert JK, Morris DL: Pronostic factors after Cryotherapic for hepatic metastases from colorectal cancer. Annals of Surgery. 228 (2): 201-208, 1998.
McAfee MK, Allen MS et al: Colorectal lung metastases: Results of surgical excision. Annals of Thoracic Surgery. 53(5): 780-786, 1992.
Rothenberg ML, Eckardt JR, et al: Phase II Trial of Irinotecan in patients with progressive or rapidly recurrent colorectal cancer. Journal of Clinical Oncology 14(4): 1128-1135, 1996.
Petrelli N, Douglas HO, et al: The modulation of Fluorouracil with Leucovorin in metastatic colorectal carcinoma: A prospective randomized phase III Trial. Jour. of Clin. Oncology 7 (10): 1419-1426, 1989.
Erlichman C, Fine S, et al: A randomized Trial of Fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. Jour. of Clinical Oncology 6(3): 469-475, 1988.
Borner MM, Castiglione M, et al: The impact of adding lowdose leucovorin to monthly 5-Fluorouracil in advanced colorectal carcinoma: Results of a phase III trial. Annals of Oncology 9(5): 535-541, 1998.
Von Hoff DD: Promising new agents for treatment of patients with colorectal cancer. Seminars in Oncology 25 (5, suppl.11): 47-52, 1998.
Cuitkovic E, Bekradda M: Oxaliplatin: A new therapeutic option in colorectal cancer. Seminars in Oncology 26(6): 647-662, 1999.
Paul CA, Virgo KS, Wade TP, Audisio RA, Johnson FE. Adrenalectomy for isolated adrenal metastases from non-adrenal cancer. Int. J. Oncol; 17(1): 181-7. 2000.
Linos DA. Management approaches to adrenal incidentalomas (adrenalomas). A view from Athens, Greece. Endocrinol. Metab. Clin. North Am.; 29(1): 141-57. 2000.
NOTA:Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.
Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO, caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit
